Logo image of BN.PA

DANONE (BN.PA) Stock Fundamental Analysis

EPA:BN - Euronext Paris - Matif - FR0000120644 - Common Stock - Currency: EUR

71.78  -0.54 (-0.75%)

Fundamental Rating

5

Taking everything into account, BN scores 5 out of 10 in our fundamental rating. BN was compared to 60 industry peers in the Food Products industry. While BN has a great profitability rating, there are some minor concerns on its financial health. BN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year BN was profitable.
In the past year BN had a positive cash flow from operations.
BN had positive earnings in each of the past 5 years.
In the past 5 years BN always reported a positive cash flow from operatings.
BN.PA Yearly Net Income VS EBIT VS OCF VS FCFBN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

The Return On Assets of BN (4.46%) is better than 68.33% of its industry peers.
BN's Return On Equity of 11.34% is fine compared to the rest of the industry. BN outperforms 68.33% of its industry peers.
BN has a Return On Invested Capital of 6.58%. This is in the better half of the industry: BN outperforms 65.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BN is in line with the industry average of 6.51%.
The 3 year average ROIC (6.38%) for BN is below the current ROIC(6.58%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.46%
ROE 11.34%
ROIC 6.58%
ROA(3y)2.83%
ROA(5y)3.44%
ROE(3y)7.34%
ROE(5y)9%
ROIC(3y)6.38%
ROIC(5y)6.21%
BN.PA Yearly ROA, ROE, ROICBN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 7.37%, BN is in the better half of the industry, outperforming 76.67% of the companies in the same industry.
BN's Profit Margin has been stable in the last couple of years.
With a decent Operating Margin value of 13.00%, BN is doing good in the industry, outperforming 76.67% of the companies in the same industry.
BN's Operating Margin has declined in the last couple of years.
BN's Gross Margin of 49.70% is fine compared to the rest of the industry. BN outperforms 73.33% of its industry peers.
In the last couple of years the Gross Margin of BN has remained more or less at the same level.
Industry RankSector Rank
OM 13%
PM (TTM) 7.37%
GM 49.7%
OM growth 3Y-1.81%
OM growth 5Y-3.08%
PM growth 3Y-1.94%
PM growth 5Y-0.54%
GM growth 3Y1.56%
GM growth 5Y0.26%
BN.PA Yearly Profit, Operating, Gross MarginsBN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BN is still creating some value.
The number of shares outstanding for BN has been increased compared to 1 year ago.
Compared to 5 years ago, BN has less shares outstanding
The debt/assets ratio for BN has been reduced compared to a year ago.
BN.PA Yearly Shares OutstandingBN.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BN.PA Yearly Total Debt VS Total AssetsBN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 2.44 indicates that BN is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.44, BN is doing good in the industry, outperforming 61.67% of the companies in the same industry.
The Debt to FCF ratio of BN is 4.89, which is a neutral value as it means it would take BN, 4.89 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 4.89, BN is doing good in the industry, outperforming 75.00% of the companies in the same industry.
BN has a Debt/Equity ratio of 0.66. This is a neutral value indicating BN is somewhat dependend on debt financing.
The Debt to Equity ratio of BN (0.66) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 4.89
Altman-Z 2.44
ROIC/WACC1.06
WACC6.21%
BN.PA Yearly LT Debt VS Equity VS FCFBN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

A Current Ratio of 0.93 indicates that BN may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.93, BN is doing worse than 75.00% of the companies in the same industry.
BN has a Quick Ratio of 0.93. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
BN's Quick ratio of 0.77 is in line compared to the rest of the industry. BN outperforms 41.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.77
BN.PA Yearly Current Assets VS Current LiabilitesBN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

BN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.47%.
The Earnings Per Share has been decreasing by -1.17% on average over the past years.
The Revenue has decreased by -0.88% in the past year.
BN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.60% yearly.
EPS 1Y (TTM)4.47%
EPS 3Y3.12%
EPS 5Y-1.17%
EPS Q2Q%6.11%
Revenue 1Y (TTM)-0.88%
Revenue growth 3Y4.08%
Revenue growth 5Y1.6%
Sales Q2Q%-0.15%

3.2 Future

BN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.60% yearly.
The Revenue is expected to grow by 3.05% on average over the next years.
EPS Next Y7.96%
EPS Next 2Y7.64%
EPS Next 3Y7.59%
EPS Next 5Y5.6%
Revenue Next Year0.8%
Revenue Next 2Y1.86%
Revenue Next 3Y2.57%
Revenue Next 5Y3.05%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BN.PA Yearly Revenue VS EstimatesBN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10B 20B 30B
BN.PA Yearly EPS VS EstimatesBN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

3

4. Valuation

4.1 Price/Earnings Ratio

BN is valuated rather expensively with a Price/Earnings ratio of 19.19.
BN's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.03. BN is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 17.07, which indicates a rather expensive current valuation of BN.
63.33% of the companies in the same industry are cheaper than BN, based on the Price/Forward Earnings ratio.
BN is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.28, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.19
Fwd PE 17.07
BN.PA Price Earnings VS Forward Price EarningsBN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BN's Enterprise Value to EBITDA ratio is in line with the industry average.
BN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 16.82
EV/EBITDA 10.75
BN.PA Per share dataBN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of BN may justify a higher PE ratio.
PEG (NY)2.41
PEG (5Y)N/A
EPS Next 2Y7.64%
EPS Next 3Y7.59%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.99%, BN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.41, BN pays a bit more dividend than its industry peers.
BN's Dividend Yield is a higher than the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.99%

5.2 History

The dividend of BN has a limited annual growth rate of 1.58%.
Dividend Growth(5Y)1.58%
Div Incr Years3
Div Non Decr Years4
BN.PA Yearly Dividends per shareBN.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

66.80% of the earnings are spent on dividend by BN. This is not a sustainable payout ratio.
BN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP66.8%
EPS Next 2Y7.64%
EPS Next 3Y7.59%
BN.PA Yearly Income VS Free CF VS DividendBN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
BN.PA Dividend Payout.BN.PA Dividend Payout, showing the Payout Ratio.BN.PA Dividend Payout.PayoutRetained Earnings

DANONE

EPA:BN (8/6/2025, 5:36:15 PM)

71.78

-0.54 (-0.75%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)07-30 2025-07-30/dmh
Earnings (Next)10-07 2025-10-07
Inst Owners48.65%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap48.91B
Analysts72.5
Price Target75.85 (5.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.99%
Yearly Dividend2.1
Dividend Growth(5Y)1.58%
DP66.8%
Div Incr Years3
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.37%
PT rev (3m)2.96%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.94%
Revenue NY rev (3m)-1.75%
Valuation
Industry RankSector Rank
PE 19.19
Fwd PE 17.07
P/S 1.79
P/FCF 16.82
P/OCF 12.77
P/B 2.75
P/tB N/A
EV/EBITDA 10.75
EPS(TTM)3.74
EY5.21%
EPS(NY)4.21
Fwd EY5.86%
FCF(TTM)4.27
FCFY5.94%
OCF(TTM)5.62
OCFY7.83%
SpS40.18
BVpS26.11
TBVpS-9.12
PEG (NY)2.41
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.46%
ROE 11.34%
ROCE 11.27%
ROIC 6.58%
ROICexc 8.06%
ROICexgc 68%
OM 13%
PM (TTM) 7.37%
GM 49.7%
FCFM 10.62%
ROA(3y)2.83%
ROA(5y)3.44%
ROE(3y)7.34%
ROE(5y)9%
ROIC(3y)6.38%
ROIC(5y)6.21%
ROICexc(3y)7.67%
ROICexc(5y)7.39%
ROICexgc(3y)52.44%
ROICexgc(5y)45.6%
ROCE(3y)10.98%
ROCE(5y)10.58%
ROICexcg growth 3Y19.7%
ROICexcg growth 5Y13.36%
ROICexc growth 3Y4.65%
ROICexc growth 5Y1.26%
OM growth 3Y-1.81%
OM growth 5Y-3.08%
PM growth 3Y-1.94%
PM growth 5Y-0.54%
GM growth 3Y1.56%
GM growth 5Y0.26%
F-Score7
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 4.89
Debt/EBITDA 2.49
Cap/Depr 79.02%
Cap/Sales 3.37%
Interest Coverage 20.69
Cash Conversion 81.04%
Profit Quality 144.05%
Current Ratio 0.93
Quick Ratio 0.77
Altman-Z 2.44
F-Score7
WACC6.21%
ROIC/WACC1.06
Cap/Depr(3y)59.49%
Cap/Depr(5y)65.43%
Cap/Sales(3y)3.2%
Cap/Sales(5y)3.59%
Profit Quality(3y)220.86%
Profit Quality(5y)178.79%
High Growth Momentum
Growth
EPS 1Y (TTM)4.47%
EPS 3Y3.12%
EPS 5Y-1.17%
EPS Q2Q%6.11%
EPS Next Y7.96%
EPS Next 2Y7.64%
EPS Next 3Y7.59%
EPS Next 5Y5.6%
Revenue 1Y (TTM)-0.88%
Revenue growth 3Y4.08%
Revenue growth 5Y1.6%
Sales Q2Q%-0.15%
Revenue Next Year0.8%
Revenue Next 2Y1.86%
Revenue Next 3Y2.57%
Revenue Next 5Y3.05%
EBIT growth 1Y2.24%
EBIT growth 3Y2.2%
EBIT growth 5Y-1.53%
EBIT Next Year35.65%
EBIT Next 3Y14.25%
EBIT Next 5Y10.75%
FCF growth 1Y11.98%
FCF growth 3Y6.14%
FCF growth 5Y3.12%
OCF growth 1Y11.24%
OCF growth 3Y3.31%
OCF growth 5Y2.15%